Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
February 1st, 2022
3K views
There are several differences between the right and left ventricles. However, the pathophysiology of right ventricular infarction (RVI) has not been clarified. In the present protocol, a reproducible method for RVI mouse model generation is introduced, which may provide a means to explain the mechanism of RVI.
Overview
This study introduces a reproducible method for generating a right ventricular infarction (RVI) mouse model. The technique aims to clarify the pathophysiological mechanisms underlying RVI, which has not been well understood.
Key Study Components
Area of Science
- Cardiovascular physiology
- Pathophysiology
- Mouse models
Background
- The right ventricle is more resistant to ischemia than the left ventricle.
- Understanding RVI is crucial for developing targeted therapies.
- Current methods for studying RVI are limited.
- This study aims to address these gaps through a novel model.
Purpose of Study
- To develop a reliable mouse model for RVI.
- To elucidate the mechanisms involved in RVI.
- To provide a platform for future research on RVI.
Methods Used
- Identification of the right coronary artery through vascular costing.
- Defining the ligation area critical for RVI model generation.
- Mouse preparation involving anesthesia and immobilization.
- Demonstration of the procedure by a trained researcher.
Main Results
- A reproducible method for generating RVI in mice was established.
- The technique allows for the study of RVI pathophysiology.
- Successful model generation was demonstrated through procedural steps.
- This model can facilitate future research into RVI mechanisms.
Conclusions
- The developed model is a valuable tool for studying RVI.
- It enhances understanding of the right ventricle's response to ischemia.
- Future studies can build on this model to explore therapeutic options.
Frequently Asked Questions
What is right ventricular infarction?
Right ventricular infarction (RVI) is a condition where the right ventricle of the heart is damaged due to a lack of blood flow.
Why is studying RVI important?
Understanding RVI is crucial for developing effective treatments for heart diseases that affect the right ventricle.
How does the new model improve research?
The new model provides a reliable method to study the mechanisms of RVI, which were previously not well understood.
What techniques are used in the model generation?
The model generation involves vascular costing to locate the right coronary artery and precise ligation techniques.
Who demonstrated the procedure?
The procedure was demonstrated by Linhai Ruo, a poster doctor from the laboratory.
What are the implications of this research?
This research may lead to better understanding and treatment options for patients with RVI.
Executive Industry Relevance
Robust preclinical models of right ventricular infarction (RVI) are essential for elucidating mechanisms of right heart failure and for identifying therapeutic targets relevant to human disease. This protocol enables reproducible generation and quantitative characterization of RVI in mice, supporting translational research and mechanistic de-risking at early discovery and preclinical stages. The model's quantitative outputs facilitate predictive confidence and portfolio triage for cardiovascular drug discovery programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of right ventricular injury mechanisms and remodeling pathways.
- Supports functional target validation for right heart failure interventions.
- Provides a platform for mechanistic de-risking of candidate targets in a disease-relevant system.
- Facilitates predictive confidence in translational hypotheses for right ventricular pathology.
Screening & Assay Development
- Delivers validated in vivo endpoints including infarct size, echocardiographic parameters, and hemodynamic measurements.
- Supports assay standardization and reproducibility for cross-study comparisons.
- Enables quantitative assessment of compound efficacy in a physiologically relevant context.
- Prepares the system for downstream screening of therapeutic candidates targeting RV remodeling.
Translational & Preclinical Research
- Aligns preclinical endpoints with clinical measures of RV function and remodeling.
- Provides continuity from mechanistic discovery to preclinical validation of therapeutic strategies.
- Supports risk-adjusted advancement decisions based on quantitative translational biomarkers.
- Facilitates evaluation of disease-modifying effects in a model mimicking patient pathophysiology.
Pipeline & Workflow Integration
This RVI model integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational validation for right heart failure programs.
- Discovery Biology: Supports hypothesis testing and pathway clarification for RV injury and remodeling.
- Screening: Provides reproducible, quantitative outputs for compound evaluation and assay development.
- Analytics: Enables measurement of infarct size, cardiac function, and hemodynamics for comparative analysis.
- Translational Research: Aligns preclinical findings with clinical endpoints relevant to RV dysfunction.
- Enterprise Reuse: Establishes a reusable in vivo platform for ongoing cardiovascular R&D initiatives.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in right heart failure research.
- Operational Value: Standardizes model generation and quantitative assessment for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by enabling early de-risking.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of cardiovascular assets targeting RV pathology.
Implementation Considerations
- Requires expertise in microsurgical techniques and small animal anesthesia.
- Demands access to echocardiography, hemodynamic monitoring, and histological analysis infrastructure.
- Necessitates cross-team standardization of procedural steps and data interpretation.
- Adaptation may be needed for different mouse strains or comorbid models.
- Success and survival rates depend on precise ligation and perioperative management.
Biopharma FAQs
Why does null hypothesis testing matter for infarct size quantification?
Null hypothesis testing in infarct size quantification enables objective assessment of intervention effects, supporting target validation and reducing false positives in early discovery. Quantitative comparison of infarct areas informs mechanistic confidence and portfolio triage decisions.
How does independent variable isolation in right coronary ligation fit the discovery pipeline?
Isolating the right coronary artery as the independent variable ensures that observed cardiac remodeling and dysfunction are attributable to RVI, strengthening mechanistic de-risking and supporting translational relevance in the discovery pipeline.
What do quantitative echocardiographic and hemodynamic measurements enable?
Quantitative measurements of RV function and hemodynamics enable reproducible assessment of disease progression and therapeutic response, facilitating cross-study comparisons and robust evaluation of candidate interventions.
Why are replication requirements critical for cross-functional collaboration in RVI studies?
Replication of infarct size, functional, and histological endpoints ensures data reliability and comparability across teams, supporting collaborative decision-making and reducing risk in multi-site R&D programs.
What statistical analysis capabilities are required before implementing RV remodeling endpoints?
Robust statistical analysis of infarct size, functional, and hemodynamic data is required to validate endpoints, establish significance thresholds, and support data-driven advancement decisions in preclinical cardiovascular research.
Chapters in this video
0:04
Introduction
0:54
Preparation for Surgery
1:37
Permanent Ligation of the Right Coronary Artery
3:03
Echocardiographic Assessment of the RV (Right Ventricle) Function After Surgery
5:25
Invasive Measurements of RV Hemodynamic
6:43
Coronary Vascular Cast Using a Vascular Casting Agent
7:49
Results: Electrocardiography, Echocardiography and Histological Assessment After Right Coronary Artery Ligation
9:48
Conclusion
